X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

MOLECULAR THERAPY

期刊標題檢索 MOL THER 最新評論: The first review took about a month to return the review comments, wit... (2026-04-22)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[MOLECULAR THERAPY]您好,您是該頁面的第 152956 位訪客。

期刊簡介
期刊名稱MOLECULAR THERAPY MOLECULAR THERAPY
LetPub Score
8.8
52 ratings
Rate

Reputation
9.6

Influence
8.1

Speed
9.1

期刊簡稱MOL THER
ISSN1525-0016
E-ISSN1525-0024
h-index158
CiteScore
CiteScoreSJRSNIPCiteScore Rank
17.903.8141.863
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q15 / 161
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q110 / 328
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Genetics
Q111 / 357
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Biology
Q125 / 414
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q113 / 179

自引率 (2023-2024)1.70%自引率趨勢
掲載範囲
Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2024 impact factor is 12.

To accommodate the rapid growth of Molecular Therapy, articles will be submitted and published in one of the following subsections (for section editors, please see the editorial board page).
官方網站https://www.cell.com/molecular-therapy-family/molecular-therapy/home
在線稿件提交https://www.editorialmanager.com/molecular-therapy/default.aspx
開放訪問Yes (Hybrid OA journal)
出版商Cell Press
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年2000
每年文章數264每年文章數趨勢
黃金OA百分比27.60%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOTECHNOLOGY & APPLIED MICROBIOLOGYSCIEQ16/177
GENETICS & HEREDITYSCIEQ15/192
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ110/195
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-0016%5BISSN%5D
平均審稿時間 *來自出版商的數據: Time to first decision: 8 days;
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【MOLECULAR THERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 159.20
    NATURE BIOTECHNOLOGYH-index: 399

    CiteScore: 66.40
    TRENDS IN BIOTECHNOLOGYH-index: 195

    CiteScore: 22.10
    BIOTECHNOLOGY ADVANCESH-index: 161

    CiteScore: 24.80
    PLANT BIOTECHNOLOGY JOURNALH-index: 96

    CiteScore: 15.20
    CRITICAL REVIEWS IN BIOTECHNOLOGYH-index: 79

    CiteScore: 20.60
    METABOLIC ENGINEERINGH-index: 101

    CiteScore: 13.90
    Biotechnology for BiofuelsH-index: 75

    CiteScore: 15.70
    CANCER GENE THERAPYH-index: 80

    CiteScore: 11.10
    FOOD MICROBIOLOGYH-index: 103

    CiteScore: 10.50
    學科內最受檢索的期刊 頁面查看次數
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY901439
    BMC GENOMICS530053
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY483488
    PLANT BIOTECHNOLOGY JOURNAL248288
    GENOMICS214117
    NATURE BIOTECHNOLOGY195948
    JOURNAL OF APPLIED MICROBIOLOGY180962
    BIOTECHNOLOGY AND BIOENGINEERING178511
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY166938
    BIOTECHNOLOGY ADVANCES166751
  •  

    MOLECULAR THERAPY MOLECULAR THERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    2    3    4    5    6    7    8    下一頁    末頁  (頁
/8)
  [MOLECULAR THERAPY] 的評論撰寫評論
作者: 黑沙静丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-09 13:00:10 評論於
My article has been in pre-acceptance for over 20 days. After uploading the final revision, the status has remained at "Revised submitted." I have emailed twice for inquiries, but have not received a response. Is this within the range of what you mean by "a little slow"?
(0) 讚! | 黑沙静丽

作者: 黑沙静丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-02 23:53:05 評論於
The article has been in pre-acceptance for over 20 days now, and it still hasn't shown as accepted. After uploading the final revision following pre-acceptance, the status has remained as "Revised submitted". I have emailed but have not received a reply. Has anyone else experienced this when submitting to MT? Should I send another email to inquire?
(0) 讚! | 黑沙静丽

作者: 奉天睿博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-25 18:53:44 評論於
I calculated it as 8.59
(0) 讚! | 奉天睿博

作者: 稻妻世霖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-30 10:09:46 評論於
What is your current status now? I was "with editor" for one week, and then it changed to "under review"
(0) 讚! | 稻妻世霖

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-21 16:03:58 評論於
What is the current time now?
(0) 讚! | 一条小醉容

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-13 22:04:54 評論於
Mine, waited about a week, turned into with editor. No need to confirm
(0) 讚! | 一条小醉容

作者: Ingram Tuttle


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-13 13:50:50 評論於
How long does it take for the manuscript to be submitted? Do we have to wait for all authors to confirm before the review?
(0) 讚! | Ingram Tuttle

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-08 23:43:35 評論於
Have you voted?
(0) 讚! | 一条小醉容

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-08 15:01:57 評論於
May I ask how long with the editor? What is the next status? Thank you
(0) 讚! | 一条小醉容

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-06 16:14:54 評論於
How long have you been with editor? What's the next step?
(0) 讚! | 一条小醉容

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-04 23:29:15 評論於
What is your current status?
(0) 讚! | 一条小醉容

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-04 20:53:59 評論於
The first step now is to submit the manuscript, right?
(0) 讚! | 一条小醉容

作者: 一条小醉容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-10-04 09:46:09 評論於
Is it necessary to do so in this way? How long does it take to receive feedback after submitting a contribution? Thank you
(0) 讚! | 一条小醉容

作者: 深渊绮晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-26 11:48:09 評論於
Be patient
(0) 讚! | 深渊绮晴

作者: 四象天晴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-17 17:49:37 評論於
This magazine seems to have become a special issue on lncRNA recently
(0) 讚! | 四象天晴

作者: 邻家盼山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-14 20:28:10 評論於
I would like to ask if the author must confirm that all authors have signed off before proceeding to the next step
(0) 讚! | 邻家盼山

作者: Louise Churchill


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-19 19:11:49 評論於
What does it mean when the status is "Not assigned editing"?
(0) 讚! | Louise Churchill

作者: 奉天睿博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-29 19:17:16 評論於
Please translate the following paragraph into English and Japanese, with titles of ":" and ":"
(0) 讚! | 奉天睿博

作者: 迷失自我的青椒


領域: 环境科学与生态学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-25 11:16:29 評論於
As a green pepper, I can't even afford a computer. However, there are certain individuals whose academic level is not that great, yet they have an endless amount of funding. Every day they rack their brains on how to spend money, and expenses like page fees can conveniently be used as a shield, otherwise a large amount of funding can easily encounter issues.
(9) 讚! | 迷失自我的青椒

作者: Walker Elsie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-13 21:27:48 評論於
May I ask how many reviewers there are?
(0) 讚! | Walker Elsie

作者: 终幕凝风


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-04 14:05:22 評論於
Do you require the original data to provide the corresponding graph for all data points?
(0) 讚! | 终幕凝风

作者: 奉天睿博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-02-01 17:54:36 評論於
Review speed: 2.0 | Submission acceptance rate: 5.0
Sharing experience: The review speed is fast, the reviewers are very professional and sharp, and they go straight to the point with each question. There is plenty of time for revisions, as long as you make an effort to address all the reviewers' comments, there should be no problem. The editor is a bit slow but very friendly. ASGCT's official journal, with an instant Impact Factor of 10.9 in February 2021, is expected to continue to rise
(0) 讚! | 奉天睿博

作者: 无相壬午


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-07 18:58:27 評論於
I submitted my article but did not receive a manuscript number, what should I do? Did anyone else experience this issue?
(0) 讚! | 无相壬午

作者: Valentina Bart


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-28 19:20:14 評論於
I have also been under review for a month. How long have you been under review? I have transferred, and this is my first time submitting to molecular therapy
(0) 讚! | Valentina Bart

作者: 雨巷少年元化


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-11 19:49:21 評論於
How long did you finally with the editor?
(0) 讚! | 雨巷少年元化

首頁    上一頁    2    3    4    5    6    7    8    下一頁    末頁  (頁
/8)

開始撰寫 [MOLECULAR THERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*